Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy

Host genetics contributes to the effectiveness of dendritic cell-based HIV immunotherapy

Systems biological analysis has recently revealed how innate immune variants as well as gut microbiota impact the individual response to immunization. HIV-infected (HIV+) patients have a worse response rate after standard vaccinations, possibly due to the immune exhaustion, increased gut permeabilit...

Full description

Bibliographic Details
Main Authors: Edione C. Reis, Lais T. da Silva, Wanessa C. da Silva, Alexandre Rios, Alberto J. Duarte, Telma M. Oshiro, Sergio Crovella, Alessandra Pontillo
Format: Article
Language:English
Published: Taylor & Francis Group 2018-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
hiv
immunotherapy
dendritic cell
genetics
pard3b
Online Access:http://dx.doi.org/10.1080/21645515.2018.1463942

Similar Items

Similar Items